PETER RUVOLO to Treatment Outcome
This is a "connection" page, showing publications PETER RUVOLO has written about Treatment Outcome.
Connection Strength
0.017
-
A heavy metal baseline score predicts outcome in acute myeloid leukemia. Am J Hematol. 2020 04; 95(4):422-434.
Score: 0.010
-
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia. Clin Cancer Res. 2014 Apr 15; 20(8):2226-35.
Score: 0.007